Non-ART | ART | |||||
---|---|---|---|---|---|---|
Services categories | Total | non-AIDS | AIDS | Total | non-AIDS | AIDS |
Outpatient services | PYO* = 80.82 | PYO = 75.24 | PYO = 5.58 | PYO = 221.98 | PYO = 181.13 | PYO = 40.85 |
Consultation at HIV Clinic | 4.6(4.3–5.0) | 4.5(4.1–4.9) | 5.9(4.0–7.9) | 11.4(11.0–11.7) | 11.4(11.0–11.8) | 11.3(10.5–12.1) |
Laboratory | ||||||
Haematology (CBC) | 4.4(4.0–4.8) | 4.3(3.9–4.9) | 5.4(3.5–7.3) | 3.1(2.96–3.2) | 3(2.9–3.2) | 3.3(2.9–3.7) |
Clinical chemistry | 1.1(0.9–1.3) | 1.1(0.8–1.3) | 1.3(0.1–2.4) | 3.1(2.9–3.2) | 3.1(2.9–3.2) | 3.2(2.8–3.6) |
CD4 | 0.0 | 0 | 0 | 0.4(0.3–0.4) | 0.4(0.3–0.4) | 0.3(0.2–0.5) |
Other tests | 0.3(0.2–0.5) | 0.3(0.2–0.4) | 0.7(0.1–1.6) | 0.3(0.2–0.4) | 0.3(0.2–0.4) | 0.4(0.2–0.5) |
Imaging | 0.7(0.5–0.9) | 0.6(0.5–0.8) | 1.6(0.6–2.6) | 0.1(0.05–0.13) | 0.1(0.0–0.1) | 0.1(0.0–0.2) |
Anti Retroviral drugs | ||||||
Zudovudine (300 mg) | 0.0 | 0 | 0 | 28.7(13.3–44.1) | 33.4(14.6–52.1) | 8.3(0.0–16.7) |
3TC (150 mg) | 0.0 | 0 | 0 | 548.2(515.2–581.1) | 551.1(515.2–587.0) | 535.0(451–618.9) |
Stavudine (d4T; 40 mg) | 0.0 | 0 | 0 | 205.1(162.4–247.8) | 224.3(175.3–273.2) | 120.4(44.9–195.8) |
Stavudine (d4T; 30 mg) | 0.0 | 0 | 0 | 317.7(268.2–367.1) | 297.7(242.6–352.8) | 406.2(294.7–517.8) |
Neverapine (200 mg) | 0.0 | 0 | 0 | 401.2(353–449.4) | 402.8(349.4–456.1) | 394.3(277.9–510.7) |
Effavirenze (600 mg) | 0.0 | 0 | 0 | 113.3(89.6–137.0) | 112.1(85.7–138.4) | 118.9(63–174.8) |
Zudovidine+3TC 450 mg | 0.0 | 0 | 0 | 88.3(59.9–116.7) | 88.6(57.2–120.1) | 86.8(18.8–154.8) |
Non-ARV drugs 1 | 10.9(8.4–13.3) | 10.0(7.6–12.4) | 22.4(7.8–37.0) | 3.8(3.1–4.5) | 3.9(3.0–4.7) | 3.5(2.6–4.5) |
Inpatient services | n = 33 | n = 13 | n = 20 | n = 25 | n = 19 | n = 6 |
Laboratory | ||||||
Haematology (CBC) | 0.9(0.7–1.0) | 0.9(0.5–1.2) | 0.9(0.6–1.1) | 0.7(0.5–0.9) | 0.7(0.5–1.0) | 0.7(0.1–1.2) |
Clinical chemistry | 0.4(0.2–0.6) | 0.3(0.1–0.7) | 0.5(0.2–0.7) | 0.4(0.2–0.7) | 0.5(0.2–0.7) | 0.3(-0.2–0.9) |
CD4 | 0.00 | 0 | 0 | 0.08(0.03–0.19) | 0.1(0.05–0.3) | 0 |
Other tests | 1.3(0.8–1.7) | 1.31(0.5–2.1) | 1.3(0.7–1.6) | 0.5(0.1–0.9) | 0.5(0.1–0.9) | 0.7(0.6–1.9) |
Imaging | 0.5(0.3–0.7) | 0.4(0.01–0.8) | 0.6(0.3–0.9) | 0.08(0.03–0.19) | 0.1(0.06–0.16) | 0.17(0.06–0.60) |
Non-ARVdrug 1 | 11.3(8.8–13.9) | 11.2(7.7–14.7) | 11.4(7.6–15.2) | 5.5(3.9–7.1) | 5.7(3.7–7.6) | 5.0(0.9–9.0) |
Mean number of inpatient days | 17.6(13.1–22.1) | 12.2(6.2–18.1) | 21.1(14.9–27.3) | 5.6(4.4–6.9 | 4.5(3.5–5.6) | 9.2(5.7–12.6) |